Company Filing History:
Years Active: 2016
Title: Jesper Säfholm: Innovator in Asthma Treatment
Introduction
Jesper Säfholm is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of asthma. His innovative approach has led to the development of a unique application of pemirolast, a compound that shows promise in managing acute asthma attacks.
Latest Patents
Jesper Säfholm holds a patent for the "Use of pemirolast in the treatment of acute asthma." This invention provides a method for utilizing pemirolast, or a pharmaceutically acceptable salt thereof, in therapeutic treatments for asthma. The patent specifies that suitable lower doses of pemirolast are at least about 110 mg per day, highlighting its potential effectiveness in acute situations.
Career Highlights
Throughout his career, Jesper has been associated with Rspr Pharma AB, a company dedicated to advancing pharmaceutical innovations. His work has focused on developing treatments that improve the quality of life for individuals suffering from respiratory conditions.
Collaborations
Jesper has collaborated with notable colleagues, including Johan Raud and Carl-Johan Dalsgaard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Jesper Säfholm's contributions to asthma treatment through his patent on pemirolast demonstrate his commitment to improving healthcare solutions. His work at Rspr Pharma AB and collaborations with fellow innovators further emphasize the importance of teamwork in advancing medical science.